LEMAITRE VASCULAR INC
Company Stats
- Market Cap
- $1.9B
- as of Sep 30, 2026
- Shares Outstanding
- 22.9M
- Free Float
- 92.6%
Income Statement
- Revenue
- $249.6M
- Operating Income
- $67.9M
- Net Income
- $57.7M
- EBITDA
- $78.3M
- Revenue Growth, 3Y
- 15.6%
- FCF Margin, 3Y Avg
- 20.7%
- FCF Margin, Worst Year
- 15.2%
Cash Flow
- Free Cash Flow
- $74.5M
- FCF Yield
- 3.9%
- Owner FCF Yield
- 3.5%
Balance Sheet
- Cash & Equivalents
- $28.2M
Returns & Capital
- Dividends Paid
- $18.1M
- Dividend Yield
- 1.0%
- Dividend Payout, 3Y Avg
- 35.1%
- Share Repurchases
- $1.8M
- Buyback Yield, 3Y Avg
- 0.1%
- SBC, 3Y Avg
- $6.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $249.6M | $74.5M | 29.8% |
| FY2024 | $219.9M | $37.2M | 16.9% |
| FY2023 | $193.5M | $29.5M | 15.2% |
| FY2022 | $161.7M | $22.1M | 13.7% |
| FY2021 | $154.4M | $30.2M | 19.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 27, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back